| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |